Member Info for share4

Those of us that bought in before this rise know why. It's all well and good listing these things but how investors value the company is a whole different ball game.

Balls deep on this now too many positive indicators

More profit in the willy wonka experience

Good lab apparently if you fancy a tour

If you hit production. Big if. And then to not run off with shareholders money if you do.

The track record is to avoid taking the mick out of shareholders when it comes to placings as far as I can see, and that transparency is not as present in non-producing explorers.

Yeah you're right HC you didn't say that about Shishir, I misread your post. Well lets see anyway, don't think there's anything wrong with having dissenting views and being cautious on these tiny explorers.

On the basis that this managed to get away a significant placing at almost 2x the current share price recently and now has the backing of a sovereign wealth fund. I don't think going out of business is as great a risk as what you're suggesting it is.

Also shishir therw a fair chunk of his own money in so I'm not sure why you think he's carrying little risk.

I also think that "more likely to execute" is something of a ramp for explorers that aren't yet producing in this current climate.

HC, what's your comparison to other stocks in this sector in relation to where the share price is at? How come there are other stocks which aren't producing anything with a larger market cap? Is the whole sector overvalued?

It looks like a solid business with potential but the problem is it's Israeli. A lot of us have been burned by Israeli stocks.

Lets see, I dumped this in the 20s but have just bought back in

The promise to exercise skill, care, and diligence in their duties includes not making incorrect claims in RNSes.

https://www.lse.co.uk/rns/PYC/agreement-with-bicycle-and-cancer-research-uk-pf7cgjifk59fec9.html

8 July 2019

Dr Jim Millen, CEO said: "to be working for the first time directly with Cancer Research UK".

https://www.lse.co.uk/rns/PYC/contract-award-63fjixig2vx7xt9.html

12 October 2022

Dr Jim Millen, CEO said: "... the first occasion on which Physiomics has worked directly with Cancer Research UK."

You ought to be fined for not being impartial and allowing a false market to be created on here for the last 4 years by removing factual posts from this forum.

Thanks for the discussion and good luck to LTH

Trench, I understand your position is as a long term investor, but with any company of this size and cash position LTH are at risk of a delisting and the company going private.

Anyone done the maths on the current cash position?

So great the price is flat, and people are getting perfectly reasonable posts removed on the board.

Groundhog day

Giving an opinion on a company isn't provocation.

Aesop's fable, the boy who cried wolf.

God are these guys still at it. Strong buy still.